-transparent.png){kind=logo}
In 20 depressed patients treated with nortriptyline (NT) there was a significant relationship between the plasma concentration of NT and the debrisoquine metabolic ratio (rs = 0.77; P less than 0.01). (The debrisoquine test was performed after stopping NT treatment). This is in agreement with the hypothesis that the hydroxylations of NT and debrisoquine are mediated by similar enzymatic mechanisms. In contrast there was no significant relationship between the debrisoquine metabolic ratio and the plasma concentrations of the active metabolite 10-hydroxy-nortriptyline. In 11 of the patients the debrisoquine metabolic ratio was significantly higher during than after NT treatment. This may be due to an inhibition of the debrisoquine hydroxylation by NT.
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
August 1981,
Clinical pharmacology and therapeutics,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
February 1996,
Psychopharmacology,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
October 1984,
Clinical pharmacology and therapeutics,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
December 1987,
Journal of chromatography,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
January 1988,
Therapeutic drug monitoring,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
January 1991,
Pharmacology & toxicology,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
October 1987,
Methods and findings in experimental and clinical pharmacology,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
January 1996,
European journal of drug metabolism and pharmacokinetics,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
January 1986,
Therapeutic drug monitoring,
C Nordin, and
B Siwers, and
J Benitez, and
L Bertilsson
March 1981,
Lancet (London, England),
